secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0001493152-24-002701
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq bid price deficiency notice; must regain compliance by July 9, 2024
--------------------------------------------------------------------------------

- Closing bid price of common stock (OCEA) below $1.00 for 30 consecutive business days through Jan 10, 2024.
- 180-day cure period ends July 9, 2024; compliance requires $1.00 closing bid for 10 consecutive business days.
- Company may seek 180-day extension if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.
- If not cured, Nasdaq will delist common stock; company can appeal to a Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224002701/0001493152-24-002701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224002701/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer